Infectious disease
BRLF1 109-117 (HLA-A*02:01) YVLDHLIVV
Product number: EP11139_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. YVLDHLIVV is a linear peptidic epitope (epitope ID76333) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.
TechData
| Sequence: | YVLDHLIVV |
| Gene: | ATF7IP |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Activating transcription factor 7-interacting protein 1 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease, Cancer, Neuroscience |
| Purity: | 95% HPLC-MS |